Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mikkel P Werge

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Plos One|June 9, 2025
The hepatic transcriptome is differentially regulated by a standardized meal in healthy individuals compared to patients with fatty liver diseaseJosephine Grandt, Christian D Johansen, Anne-Sofie H Jensen, et al.
Physiological Reports|April 20, 2023
Postprandial dysfunction in fatty liver diseaseJosephine Grandt, Anne-Sofie H Jensen, Mikkel P Werge, et al.
Hepatology Communications|September 1, 2023
Suboptimal diagnostic accuracy of ultrasound and CT for compensated cirrhosis: Evidence from prospective cohort studiesLiv E Hetland, Thit M Kronborg, Mira Thing, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|March 13, 2020
Cardiodynamic state is associated with systemic inflammation and fatal acute-on-chronic liver failureMichael Praktiknjo, Sofia Monteiro, Josephine Grandt, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|August 6, 2024
Hepatic steatosis and not type 2 diabetes, body mass index, or hepatic fibrosis associates with hyperglucagonemia in individuals with steatotic liver diseaseSasha A S Kjeldsen, Mikkel P Werge, Josephine Grandt, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|April 16, 2024
Patients with autoimmune liver disease have glucose disturbances that mechanistically differ from steatotic liver diseaseAnne-Sofie H Jensen, Henriette Ytting, Mikkel P Werge, et al.
Iscience|November 13, 2023
Neprilysin activity is increased in metabolic dysfunction-associated steatotic liver disease and normalizes after bariatric surgery or GLP-1 therapySasha A S Kjeldsen, Lise L Gluud, Mikkel P Werge, et al.
Journal of Hepatology|May 11, 2026
Arachidonoyl-taurine is elevated in human MASLD and protects against hepatic steatosis and inflammation in preclinical modelsKatharina B Kuentzel, Samuel A J Trammell, Anna S Hassing, et al.
Molecular Metabolism|September 16, 2020
Glucagon acutely regulates hepatic amino acid catabolism and the effect may be disturbed by steatosisMarie Winther-Sørensen, Katrine D Galsgaard, Alberto Santos, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Plos One|June 9, 2025
The hepatic transcriptome is differentially regulated by a standardized meal in healthy individuals compared to patients with fatty liver diseaseJosephine Grandt, Christian D Johansen, Anne-Sofie H Jensen, et al.
Physiological Reports|April 20, 2023
Postprandial dysfunction in fatty liver diseaseJosephine Grandt, Anne-Sofie H Jensen, Mikkel P Werge, et al.
Hepatology Communications|September 1, 2023
Suboptimal diagnostic accuracy of ultrasound and CT for compensated cirrhosis: Evidence from prospective cohort studiesLiv E Hetland, Thit M Kronborg, Mira Thing, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|March 13, 2020
Cardiodynamic state is associated with systemic inflammation and fatal acute-on-chronic liver failureMichael Praktiknjo, Sofia Monteiro, Josephine Grandt, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|August 6, 2024
Hepatic steatosis and not type 2 diabetes, body mass index, or hepatic fibrosis associates with hyperglucagonemia in individuals with steatotic liver diseaseSasha A S Kjeldsen, Mikkel P Werge, Josephine Grandt, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|April 16, 2024
Patients with autoimmune liver disease have glucose disturbances that mechanistically differ from steatotic liver diseaseAnne-Sofie H Jensen, Henriette Ytting, Mikkel P Werge, et al.
Iscience|November 13, 2023
Neprilysin activity is increased in metabolic dysfunction-associated steatotic liver disease and normalizes after bariatric surgery or GLP-1 therapySasha A S Kjeldsen, Lise L Gluud, Mikkel P Werge, et al.
Journal of Hepatology|May 11, 2026
Arachidonoyl-taurine is elevated in human MASLD and protects against hepatic steatosis and inflammation in preclinical modelsKatharina B Kuentzel, Samuel A J Trammell, Anna S Hassing, et al.
Molecular Metabolism|September 16, 2020
Glucagon acutely regulates hepatic amino acid catabolism and the effect may be disturbed by steatosisMarie Winther-Sørensen, Katrine D Galsgaard, Alberto Santos, et al.
Pageof 1